Morgan Stanley upgrades Johnson & Johnson, sees upside on robust drug pipeline
- Posted on January 28, 2026
- By CNBC
- 3 Views
Morgan Stanley upgrades Johnson & Johnson, sees upside on robust drug pipeline
Morgan Stanley's price target implies that shares of Johnson & Johnson could rise another 17%.
